Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bountra

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Oncology|June 1, 1996
Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugsC Bountra, J D Gale, C J Gardner, et al.
Neuroimage|July 5, 2008
Volunteer studies in pain research--opportunities and challenges to replace animal experiments: the report and recommendations of a Focus on Alternatives workshopC K Langley, Q Aziz, C Bountra, et al.
European Journal of Pain (London, England)|December 21, 2012
Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neuronsU Anand, P Facer, Y Yiangou, et al.
Neuroscience Letters|February 17, 2006
The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neuronsU Anand, W R Otto, M A Casula, et al.
Brain Research|March 20, 1999
Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painM J Hudspith, S Harrisson, G Smith, et al.
Lancet (London, England)|February 8, 2003
Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgencyC L H Chan, P Facer, J B Davis, et al.
British Journal of Pharmacology|December 1, 1995
The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040C J Gardner, D J Twissell, T J Dale, et al.
Brain Research|March 20, 1999
Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painR Munglani, M J Hudspith, B Fleming, et al.
Endocrine-Related Cancer|January 15, 2020
Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cellsK E Lines, P Filippakopoulos, M Stevenson, et al.
Neurogastroenterology and Motility|June 3, 1999
The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted ratN M Clayton, R Sargent, A Butler, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Oncology|June 1, 1996
Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugsC Bountra, J D Gale, C J Gardner, et al.
Neuroimage|July 5, 2008
Volunteer studies in pain research--opportunities and challenges to replace animal experiments: the report and recommendations of a Focus on Alternatives workshopC K Langley, Q Aziz, C Bountra, et al.
European Journal of Pain (London, England)|December 21, 2012
Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neuronsU Anand, P Facer, Y Yiangou, et al.
Neuroscience Letters|February 17, 2006
The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neuronsU Anand, W R Otto, M A Casula, et al.
Brain Research|March 20, 1999
Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painM J Hudspith, S Harrisson, G Smith, et al.
Lancet (London, England)|February 8, 2003
Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgencyC L H Chan, P Facer, J B Davis, et al.
British Journal of Pharmacology|December 1, 1995
The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040C J Gardner, D J Twissell, T J Dale, et al.
Brain Research|March 20, 1999
Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic painR Munglani, M J Hudspith, B Fleming, et al.
Endocrine-Related Cancer|January 15, 2020
Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cellsK E Lines, P Filippakopoulos, M Stevenson, et al.
Neurogastroenterology and Motility|June 3, 1999
The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted ratN M Clayton, R Sargent, A Butler, et al.
Pageof 5